6 вынікі
FIELD OF THE INVENTION
The present invention relates to novel compounds, pharmaceutical compositions containing said compounds and their use in the treatment of inflammatory disorders.
BACKGROUND OF THE INVENTION
Inflammation is commonly divided into three phases: acute inflammation, the immune
FIELD OF THE INVENTION
This invention relates to pharmaceutical preparations (which expression is herein intended to include veterinary preparations) for use in combating infective organisms afflicting the animal body (which expression is herein intended to include the human body).
This invention
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of PCT International Applications PCT/ZA01/00098, PCT/ZA01/00099, and PCT/ZA01/00100, all filed Jul. 19, 2001, and all designating the U.S.
FIELD OF THE INVENTION
This invention relates to pharmaceutical preparations
This application is a national phase application under 35 U.S.C. .sctn.371 of International Application No. PCT/IN2010/000021 filed 12 Jan. 2010, which claims priority to Indian Application No. 45/DEL/2009 filed 12 Jan. 2009. The entire text of each of the above-referenced disclosures is
TECHNICAL FIELD
The invention relates to methods for reversing acute and/or chronic autonomic damage by the suppression of pro-inflammatory cytokines.
INTRODUCTION
The automatic nervous system (ANS) regulates "involuntary" organs. The ANS includes the sympathetic nervous system and the
FIELD OF THE INVENTION
The invention relates in general, to a novel oil extracted from the seeds of Momordica charantia L., (bitter gourd), its preparation and use as anti-inflammatory, anti-arthritic, vasculodilatory and wound healing agent.
BACKGROUND
The invention relates to a novel oil extracted